as most of them were negative for the T cell markers CD3, CD4 and CCR6; they were, however, positive for mast cell tryptase (MCT), a specific marker of mast cells. Having identified mast cells as ...

Marker Therapeutics to receive two grants from NIH Small Business Innovation Research (SBIR) program to support clinical investigation of MT-601 in patients with lymphoma and metastatic pancreatic ...